The Board denied a compensable rating for pseudofolliculitis barbae prior to May 17, 2022, and a rating greater than 10 percent thereafter.
The deciding factor: The evidence did not support the criteria for a higher rating as there were no characteristic lesions involving more than 5% of the body or exposed areas affected, nor was intermittent systemic therapy required for less than 6 weeks over the last 12 months prior to May 17, 2022. After that date, the evidence did not support a finding of characteristic lesions involving 20-40% of the entire body or exposed areas affected.
- Claimed conditions
- pseudofolliculitis barbae
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- October 8, 2025
- Citation
- A25086974
Want to see how appeals like this one tend to go? Appeals like mine
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.